JPS61271984A - 無血清培地 - Google Patents
無血清培地Info
- Publication number
- JPS61271984A JPS61271984A JP11228485A JP11228485A JPS61271984A JP S61271984 A JPS61271984 A JP S61271984A JP 11228485 A JP11228485 A JP 11228485A JP 11228485 A JP11228485 A JP 11228485A JP S61271984 A JPS61271984 A JP S61271984A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- medium
- blood serum
- culture medium
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004017 serum-free culture medium Substances 0.000 title abstract description 3
- 210000004369 blood Anatomy 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract description 44
- 208000032839 leukemia Diseases 0.000 claims abstract description 11
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 7
- 239000008103 glucose Substances 0.000 claims abstract description 7
- 210000002966 serum Anatomy 0.000 claims abstract description 6
- 239000012679 serum free medium Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 4
- 230000007423 decrease Effects 0.000 abstract description 4
- 241000283690 Bos taurus Species 0.000 abstract description 2
- 241000699800 Cricetinae Species 0.000 abstract description 2
- 241000282414 Homo sapiens Species 0.000 abstract description 2
- 241000124008 Mammalia Species 0.000 abstract description 2
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 2
- 241000700159 Rattus Species 0.000 abstract description 2
- 239000001963 growth medium Substances 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 238000012136 culture method Methods 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 102000016605 B-Cell Activating Factor Human genes 0.000 description 1
- 108010028006 B-Cell Activating Factor Proteins 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 208000008720 Bone Marrow Neoplasms Diseases 0.000 description 1
- 101100493543 Caenorhabditis elegans atl-1 gene Proteins 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 201000006491 bone marrow cancer Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- -1 phospho Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000005238 principal cell Anatomy 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11228485A JPS61271984A (ja) | 1985-05-27 | 1985-05-27 | 無血清培地 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11228485A JPS61271984A (ja) | 1985-05-27 | 1985-05-27 | 無血清培地 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61271984A true JPS61271984A (ja) | 1986-12-02 |
| JPS6341557B2 JPS6341557B2 (enrdf_load_stackoverflow) | 1988-08-17 |
Family
ID=14582839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11228485A Granted JPS61271984A (ja) | 1985-05-27 | 1985-05-27 | 無血清培地 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61271984A (enrdf_load_stackoverflow) |
-
1985
- 1985-05-27 JP JP11228485A patent/JPS61271984A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6341557B2 (enrdf_load_stackoverflow) | 1988-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mülling et al. | How structures in bovine hoof epidermis are influenced by nutritional factors. | |
| Nakabayashi et al. | Growth of human hepatoma cell lines with differentiated functions in chemically defined medium | |
| KR860000897B1 (ko) | 인체 에리트로포이에틴의 제조방법 | |
| McGowan et al. | Pyruvate promotion of DNA synthesis in serum-free primary cultures of adult rat hepatocytes | |
| LaBrecque | Hepatic stimulator substance: discovery, characteristics and mechanism of action | |
| Ehrke et al. | Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice | |
| Hawrylowicz et al. | Regulation of antigen-presentation-I. IFN-gamma induces antigen-presenting properties on B cells. | |
| McAuslan et al. | Stimulation of endothelial cell proliferation by precursors of thymidylate | |
| JP2001149069A (ja) | ナチュラルキラー細胞の増殖方法 | |
| JPS585671B2 (ja) | ヒト卵胞刺激ホルモンの製造方法 | |
| Piguet et al. | Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells | |
| CN105524882A (zh) | 用于免疫杀伤细胞体外扩增的血清替代物组合 | |
| US5468635A (en) | In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme | |
| JPS61271984A (ja) | 無血清培地 | |
| Aizawa et al. | Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal cell function | |
| Naughton et al. | Hematopoiesis on suspended nylon screen-stromal cell microenvironments | |
| Hata | Age-dependent changes in collagen metabolism and response to hypertonic culture conditions of rat aortic smooth muscle cells and skin fibroblasts | |
| JPS5825440B2 (ja) | ヒトカルシトニンの製造方法 | |
| CN112522196A (zh) | 一种nk细胞培养基和应用 | |
| AT413700B (de) | Mediumzusätze für zellkultur enthaltend aceton | |
| Fermín et al. | Canine long-term bone marrow culture neutrophil production and functionality | |
| JP2004135672A (ja) | 動物細胞又は組織を培養するための、ポリエチレングリコールを含んで成る組成物 | |
| JPS6251983A (ja) | ヒト／ヒト・ハイブリド−マ培養用無血清培地 | |
| Edström et al. | Isolation of mouse liver cells: perfusion technique and metabolic evaluation | |
| EP0498992A2 (en) | Serum-free culture medium containing lysozyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |